Literature DB >> 23475433

Electrophysiological study for comparing the effect of biological activity between type A botulinum toxins in rat gastrocnemius muscle.

C-S Kim1, W S Jang, I P Son, S H Nam, Y I Kim, K Y Park, B J Kim, M N Kim.   

Abstract

BACKGROUND: New cosmetic applications and products based on the effects of botulinum toxin (BTX) treatment have stimulated demand for this class of natural compounds. This demand generates the need for appropriate standardized protocols to test and compare the effectiveness of new BTX preparations.
OBJECTIVES: Based on the previously described electrophysiological methods, we measured and compared the inhibitory effects of two BTX type A (BTX-A) preparations on neuromuscular transmission through split-body test.
METHODS: The effectiveness was evaluated in terms of the compound muscle action potential (CMAP) and conduction velocity after BTX-A injection. We used a split-body method to compare two different BTX-As in the rat.
RESULTS: Based on the changes in the CMAP, the two different BTX-As induced paralytic effect on the rat tibialis anterior muscle. However, the two different BTX-A preparations did not differ significantly in effectiveness and did not induce a delay in conduction velocity.
CONCLUSIONS: The new BTX-A preparation used in this electrophysiological study had similar effect compared with the previously marketed BTX-A.[AQ: Please approve the edits made to the sentence "The new BTX-A preparation…") We propose that a split-body electrophysiological protocol will be useful in establishing the comparative effectiveness of new BTX products.

Entities:  

Keywords:  Botulinum toxin; compound muscle action potential; toxicity assay

Mesh:

Substances:

Year:  2013        PMID: 23475433     DOI: 10.1177/0960327113479044

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  5 in total

1.  Comparative functional analysis of mice after local injection with botulinum neurotoxin A1, A2, A6, and B1 by catwalk analysis.

Authors:  Molly S Moritz; William H Tepp; Heather N'te Inzalaco; Eric A Johnson; Sabine Pellett
Journal:  Toxicon       Date:  2019-06-07       Impact factor: 3.033

Review 2.  Biotoxins in muscle regeneration research.

Authors:  Mohamed A A Mahdy
Journal:  J Muscle Res Cell Motil       Date:  2019-07-29       Impact factor: 2.698

3.  The Effect of Intragastric Administration of Botulinum Toxin Type A on Reducing Adiposity in a Rat Model of Obesity Using Micro-CT and Histological Examinations.

Authors:  Jin-Seok Park; Hong-Mei Zheng; Jae-Min Kim; Chung Sei Kim; Seok Jeong; Don Haeng Lee
Journal:  Gut Liver       Date:  2017-11-15       Impact factor: 4.519

4.  Efficacy and Safety of Botulinum Toxin Type A (NABOTA) for Post-stroke Upper Extremity Spasticity: A Multicenter Phase IV Trial.

Authors:  Wonjae Hwang; Seong Min Kang; Sang Yoon Lee; Han Gil Seo; Yoon Ghil Park; Bum Sun Kwon; Kwang Jae Lee; Deog Young Kim; Hyoung Seop Kim; Shi-Uk Lee
Journal:  Ann Rehabil Med       Date:  2022-08-31

5.  Safety, efficacy, and onset of a novel botulinum toxin type A (Nabota) for the treatment of glabellar frown lines: a single-arm, prospective, phase 4 clinical study.

Authors:  Sinyoung Song; Yeon Hoon Lee; Joon Pio Hong; Tae Suk Oh
Journal:  Arch Craniofac Surg       Date:  2018-09-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.